Text: H.R.3991 — 115th Congress (2017-2018)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (10/06/2017)


115th CONGRESS
1st Session
H. R. 3991


To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.


IN THE HOUSE OF REPRESENTATIVES

October 6, 2017

Ms. Michelle Lujan Grisham of New Mexico introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to dispense narcotic drugs for maintenance or detoxification treatment pursuant to the same waiver provisions as apply with respect to nurse practitioners and physician assistants.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Expanded Access to Opioid Abuse Treatment Act of 2017”.

SEC. 2. Eligibility of certain pharmacists for waivers for dispensing narcotic drugs for maintenance or detoxification treatment.

Section 303(g)(2)(G)(iv) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)(iv)) is amended—

(1) by striking “nurse practitioner or physician assistant” each place it appears and inserting “nurse practitioner, physician assistant, or pharmacist”; and

(2) in subclause (II)(aa), by inserting “the American Pharmacists Association,” before “or any other organization”.